Jack Stroud
Clinical Psychologist; Trainee Clinical Psychologist at University College London (UCL)
Data updated
Research Footprint
Jack Stroud appears in 5 tracked papers (2017–2024), most studied alongside Psilocybin, DMT and LSD, across Depressive Disorders, Anxiety Disorders and Substance Use Disorders (SUD).
Most-cited paper: Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression (100 citations).
Frequent co-authors: Robin Carhart-Harris, David Nutt and Otto Simonsson.
Background & Research
Jack Stroud is a clinical psychologist trained at UCL, with research focused on psychopharmacology and the adverse effects and potential therapeutic effects of psychedelic drugs. His publications include studies on psilocybin-assisted emotion recognition in treatment-resistant depression, psychedelic use and meditation, and self-reported psychedelic experiences in autistic adults. He also maintains a clinical practice and describes prior experience in NHS adult mental health services.
Key Impact
Jack Stroud is a clinical psychologist and psychedelic researcher whose work spans psilocybin, autism, and psychedelic-related changes in mental health and social functioning.
Collaboration Network
10 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Jack Stroud is associated with.
University College London
academicThe Understanding Neuroplasticity Induced by Tryptamines (UNITY) Project was launched at University College London. UNITY represents the first-in-human study of psychedelics at UCL. The team utilizes techniques such as fMRI, eye-tracking and experience sampling to enhance our understanding of the neurobiological mechanisms predicting cognitive and mental health outcomes following psychedelic use, initially investigating the effects of DMT.
View stakeholder →Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →